OSMCX | RAIRX | OSMCX / RAIRX | |
Total Expense Ratio | 2.13 | 1.01 | 211% |
Annual Report Gross Expense Ratio | 2.13 | 1.06 | 201% |
Fund Existence | 28 years | 8 years | - |
Gain YTD | 15.235 | 24.783 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.5B | 390M | 898% |
Annual Yield % from dividends | 0.47 | 0.17 | 275% |
Returns for 1 year | -4.51 | 19.50 | -23% |
Returns for 3 years | 17.62 | 43.83 | 40% |
Returns for 5 years | -26.82 | 5.94 | -452% |
Returns for 10 years | 5.39 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNNX | 75.60 | 0.47 | +0.63% |
Janus Henderson Global Life Sciences N | |||
GSMVX | 16.78 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Instl | |||
RLBCX | 38.75 | 0.04 | +0.10% |
American Funds American Balanced R3 | |||
SGQAX | 46.26 | -0.03 | -0.06% |
DWS International Growth A | |||
TPISX | 14.04 | -0.08 | -0.57% |
Nuveen Quant Intl Small Cap Eq Premier |